APO RESEARCH · REPORT
Emergency Contraceptive Pills
The prevention of pregnancy after unprotected vaginal intercourse. Emergency contraception may use drugs related to the female hormones estragon and progesterone. These "morning-after pill" are similar to birth control pills but generally contain higher hormone doses.
Product & engineering
Understand the product.
The prevention of pregnancy after unprotected vaginal intercourse. Emergency contraception may use drugs related to the female hormones estragon and progesterone. These "morning-after pill" are similar to birth control pills but generally contain higher hormone doses.
Selected research
Industry Research
Emergency Contraceptive Pills Industry Research Report 2026
Market perspective
The prevention of pregnancy after unprotected vaginal intercourse. Emergency contraception may use drugs related to the female hormones estragon and progesterone. These "morning-after pill" are similar to birth control pills but generally contain higher hormone doses.
The major players in global Emergency Contraceptive Pills market include Foundation Consumer Healthcare, Gedeon Richter, Zizhu Pharma, etc. The top 3 players occupy about 55% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 75% of the global market. Levonorgestrel is the main type, with a share over 95%. Offline is the main application, which holds a share about 90%.
Report Scope
Read the full market overview
This report quantifies the global Emergency Contraceptive Pills market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Emergency Contraceptive Pills Market by Company
Foundation Consumer Healthcare
Gedeon Richter
Zizhu Pharma
Zhejiang Xianju Pharma
HRA Pharma
Regenex
Mankind Pharma
Piramal
Lupin
Syzygy Healthcare
HLL Life Care
Emergency Contraceptive Pills Segment by Type
Levonorgestrel
Ulipristal Acetate
Emergency Contraceptive Pills Segment by Distribution Channel
Online
Offline
Emergency Contraceptive Pills Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emergency Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Emergency Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emergency Contraceptive Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Emergency Contraceptive Pills manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Emergency Contraceptive Pills by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Emergency Contraceptive Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel
- Ulipristal Acetate
Applications
- Online
- Offline
Companies covered
- Foundation Consumer Healthcare
- Gedeon Richter
- Zizhu Pharma
- Zhejiang Xianju Pharma
- HRA Pharma
- Regenex
- Mankind Pharma
- Piramal
- Lupin
- Syzygy Healthcare
- HLL Life Care
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Emergency Contraceptive Pills Market Size (2021-2032)
- 2.2.2 Global Emergency Contraceptive Pills Sales (2021-2032)
- 2.2.3 Global Emergency Contraceptive Pills Market Average Price (2021-2032)
- 2.3 Emergency Contraceptive Pills by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Levonorgestrel
- 2.3.3 Ulipristal Acetate
- 2.4 Emergency Contraceptive Pills by Distribution Channel
- 2.4.1 Market Value Comparison by Distribution Channel (2021 VS 2025 VS 2032)
- 2.4.2 Online
- 2.4.3 Offline
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Emergency Contraceptive Pills Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Emergency Contraceptive Pills Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Emergency Contraceptive Pills Revenue of Manufacturers (2021-2026)
- 3.4 Global Emergency Contraceptive Pills Average Price by Manufacturers (2021-2026)
- 3.5 Global Emergency Contraceptive Pills Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Emergency Contraceptive Pills, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Emergency Contraceptive Pills, Product Type & Application
- 3.8 Global Manufacturers of Emergency Contraceptive Pills, Established Date
- 3.9 Global Emergency Contraceptive Pills Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Foundation Consumer Healthcare
- 4.1.1 Foundation Consumer Healthcare Company Information
- 4.1.2 Foundation Consumer Healthcare Business Overview
- 4.1.3 Foundation Consumer Healthcare Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Foundation Consumer Healthcare Emergency Contraceptive Pills Product Portfolio
- 4.1.5 Foundation Consumer Healthcare Recent Developments
- 4.2 Gedeon Richter
- 4.2.1 Gedeon Richter Company Information
- 4.2.2 Gedeon Richter Business Overview
- 4.2.3 Gedeon Richter Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Gedeon Richter Emergency Contraceptive Pills Product Portfolio
- 4.2.5 Gedeon Richter Recent Developments
- 4.3 Zizhu Pharma
- 4.3.1 Zizhu Pharma Company Information
- 4.3.2 Zizhu Pharma Business Overview
- 4.3.3 Zizhu Pharma Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zizhu Pharma Emergency Contraceptive Pills Product Portfolio
- 4.3.5 Zizhu Pharma Recent Developments
- 4.4 Zhejiang Xianju Pharma
- 4.4.1 Zhejiang Xianju Pharma Company Information
- 4.4.2 Zhejiang Xianju Pharma Business Overview
- 4.4.3 Zhejiang Xianju Pharma Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zhejiang Xianju Pharma Emergency Contraceptive Pills Product Portfolio
- 4.4.5 Zhejiang Xianju Pharma Recent Developments
- 4.5 HRA Pharma
- 4.5.1 HRA Pharma Company Information
- 4.5.2 HRA Pharma Business Overview
- 4.5.3 HRA Pharma Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HRA Pharma Emergency Contraceptive Pills Product Portfolio
- 4.5.5 HRA Pharma Recent Developments
- 4.6 Regenex
- 4.6.1 Regenex Company Information
- 4.6.2 Regenex Business Overview
- 4.6.3 Regenex Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Regenex Emergency Contraceptive Pills Product Portfolio
- 4.6.5 Regenex Recent Developments
- 4.7 Mankind Pharma
- 4.7.1 Mankind Pharma Company Information
- 4.7.2 Mankind Pharma Business Overview
- 4.7.3 Mankind Pharma Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mankind Pharma Emergency Contraceptive Pills Product Portfolio
- 4.7.5 Mankind Pharma Recent Developments
- 4.8 Piramal
- 4.8.1 Piramal Company Information
- 4.8.2 Piramal Business Overview
- 4.8.3 Piramal Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Piramal Emergency Contraceptive Pills Product Portfolio
- 4.8.5 Piramal Recent Developments
- 4.9 Lupin
- 4.9.1 Lupin Company Information
- 4.9.2 Lupin Business Overview
- 4.9.3 Lupin Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lupin Emergency Contraceptive Pills Product Portfolio
- 4.9.5 Lupin Recent Developments
- 4.10 Syzygy Healthcare
- 4.10.1 Syzygy Healthcare Company Information
- 4.10.2 Syzygy Healthcare Business Overview
- 4.10.3 Syzygy Healthcare Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Syzygy Healthcare Emergency Contraceptive Pills Product Portfolio
- 4.10.5 Syzygy Healthcare Recent Developments
- 4.11 HLL Life Care
- 4.11.1 HLL Life Care Company Information
- 4.11.2 HLL Life Care Business Overview
- 4.11.3 HLL Life Care Emergency Contraceptive Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 HLL Life Care Emergency Contraceptive Pills Product Portfolio
- 4.11.5 HLL Life Care Recent Developments
5 Global Emergency Contraceptive Pills Market Scenario by Region
- 5.1 Global Emergency Contraceptive Pills Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Emergency Contraceptive Pills Sales by Region: 2021-2032
- 5.2.1 Global Emergency Contraceptive Pills Sales by Region: 2021-2026
- 5.2.2 Global Emergency Contraceptive Pills Sales by Region: 2027-2032
- 5.3 Global Emergency Contraceptive Pills Revenue by Region: 2021-2032
- 5.3.1 Global Emergency Contraceptive Pills Revenue by Region: 2021-2026
- 5.3.2 Global Emergency Contraceptive Pills Revenue by Region: 2027-2032
- 5.4 North America Emergency Contraceptive Pills Market Facts & Figures by Country
- 5.4.1 North America Emergency Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Emergency Contraceptive Pills Sales by Country (2021-2032)
- 5.4.3 North America Emergency Contraceptive Pills Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Emergency Contraceptive Pills Market Facts & Figures by Country
- 5.5.1 Europe Emergency Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Emergency Contraceptive Pills Sales by Country (2021-2032)
- 5.5.3 Europe Emergency Contraceptive Pills Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Emergency Contraceptive Pills Market Facts & Figures by Country
- 5.6.1 Asia Pacific Emergency Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Emergency Contraceptive Pills Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Emergency Contraceptive Pills Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Emergency Contraceptive Pills Market Facts & Figures by Country
- 5.7.1 South America Emergency Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Emergency Contraceptive Pills Sales by Country (2021-2032)
- 5.7.3 South America Emergency Contraceptive Pills Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Emergency Contraceptive Pills Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Emergency Contraceptive Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Emergency Contraceptive Pills Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Emergency Contraceptive Pills Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Emergency Contraceptive Pills Sales by Type (2021-2032)
- 6.1.1 Global Emergency Contraceptive Pills Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Emergency Contraceptive Pills Sales Market Share by Type (2021-2032)
- 6.2 Global Emergency Contraceptive Pills Revenue by Type (2021-2032)
- 6.2.1 Global Emergency Contraceptive Pills Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Emergency Contraceptive Pills Revenue Market Share by Type (2021-2032)
- 6.3 Global Emergency Contraceptive Pills Price by Type (2021-2032)
7 Segment by Distribution Channel
- 7.1 Global Emergency Contraceptive Pills Sales by Distribution Channel (2021-2032)
- 7.1.1 Global Emergency Contraceptive Pills Sales by Distribution Channel (2021-2032) & (M Units)
- 7.1.2 Global Emergency Contraceptive Pills Sales Market Share by Distribution Channel (2021-2032)
- 7.2 Global Emergency Contraceptive Pills Revenue by Distribution Channel (2021-2032)
- 7.2.1 Global Emergency Contraceptive Pills Sales by Distribution Channel (2021-2032) & (US$ Million)
- 7.2.2 Global Emergency Contraceptive Pills Revenue Market Share by Distribution Channel (2021-2032)
- 7.3 Global Emergency Contraceptive Pills Price by Distribution Channel (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Emergency Contraceptive Pills Value Chain Analysis
- 8.1.1 Emergency Contraceptive Pills Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Emergency Contraceptive Pills Production Mode & Process
- 8.2 Emergency Contraceptive Pills Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Emergency Contraceptive Pills Distributors
- 8.2.3 Emergency Contraceptive Pills Customers
9 Global Emergency Contraceptive Pills Analyzing Market Dynamics
- 9.1 Emergency Contraceptive Pills Industry Trends
- 9.2 Emergency Contraceptive Pills Industry Drivers
- 9.3 Emergency Contraceptive Pills Industry Opportunities and Challenges
- 9.4 Emergency Contraceptive Pills Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst